A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients

Kidney transplant recipients receiving calcineurin inhibitor-based immunosuppression incur increased long-term risks of cancer and kidney fibrosis. Switch to mammalian target of rapamycin (mTOR) inhibitors may reduce these risks. Steroid or Cyclosporin Removal After Transplant using Everolimus (SOCR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transpl Int
Main Authors: Chadban, Steven J, Eris, Josette Marie, Kanellis, John, Pilmore, Helen, Lee, Po Chang, Lim, Soo Kun, Woodcock, Chad, Kurstjens, Nicol, Russ, Graeme
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282427/
https://ncbi.nlm.nih.gov/pubmed/24279685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.12252
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados